Sign in
Active, not recruitingNo phase

Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

Key facts

Who runs it
University of Wuerzburg
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
150 people enrolled
Started
Sept 2005
Expected to end
Dec 2030
Type of study
Observational
Record updated
7 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • patients with histological proven adrenocortical carcinoma
  • healthy persons as control group
  • Life expectancy > 6 months

Who cannot take part

  • autoimmune diseases
  • severe clinical condition

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy with poor prognosis. Surgical resection of the tumor is the treatment of choice. However, even after complete resection more than 80 % of patients will experience recurrence of disease. Therefore, new treatment options are urgently needed. This pre-clinical study try to lay the foundations for a successful immunotherapy in patients with ACC.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Präklinische Studie Zur Etablierung Einer Immuntherapie für Das Nebennierenrindenkarzinom - Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
Record updated
7 May 2026